| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
EPIDEMIOLOGY |
1,2Divisions of Medical Microbiology1 and Veterinary Pathology2, University of Edinburgh, Edinburgh EH8 9AG, UK 3Royal Victoria Hospital, Edinburgh, UK
Correspondence Ian R. Poxton i.r.poxton{at}ed.ac.uk
Received 29 July 2002 Accepted 6 December 2002
Clostridium difficile-associated disease continues to be a major problem in hospitals and long-term care facilities throughout the developed world. Administration of certain antibiotics such as amoxycillin, oral cephalosporins and clindamycin is associated with the greatest risk of developing C. difficile disease. The two antibiotics used for treatment of C. difficile disease are vancomycin and metronidazole, to which there is currently very little resistance. Randomly selected isolates (186) from 90 patients being investigated during an 18-month epidemiological study into the disease were tested for their susceptibility to vancomycin, metronidazole, amoxycillin, clindamycin, cefoxitin and ceftriaxone by the NCCLS agar dilution method. There was a narrow range of MIC for the two treatment agents (vancomycin and metronidazole), from 0.5 to 4 µg ml-1, with no evidence of resistance. All strains were resistant to cefoxitin (MIC 64–256 µg ml-1), the antibiotic used in most selective media. All strains were of similar sensitivity to amoxycillin (MIC90= 4 µg ml-1). Most strains were resistant to ceftriaxone (MIC 
64 µg ml-1) or of intermediate resistance (MIC 32 µg ml-1), with only two sensitive strains (MIC 16 µg ml-1). Clindamycin resistance was common, with 67 % of strains resistant (MIC 8 µg ml-1), 25 % with intermediate resistance (MIC 4 µg ml-1) and only 8 % sensitive (MIC 
2 µg ml-1). Twelve isolates from six different patients had very high resistance to clindamycin (MIC 128 µg ml-1). Multiple isolates from the same patient, taken at different times, showed changes in susceptibility patterns over time. The only major change in susceptibility over the time-period was in clindamycin resistance; some strains appeared to become more resistant while others became less resistant. No differences were seen in the MIC50 and MIC90 of the different S-types of C. difficile identified, although some S-types were present in very small numbers. There was no correlation between the antibiotics prescribed and susceptibility.
This article has been cited by other articles:
|
|
 |
|
  E. Mutlu, A. J. Wroe, K. Sanchez-Hurtado, J. S. Brazier, and I. R. Poxton Molecular characterization and antimicrobial susceptibility patterns of Clostridium difficile strains isolated from hospitals in south-east Scotland J. Med. Microbiol., July 1, 2007; 56(7): 921 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Rea, E. Clayton, P. M. O'Connor, F. Shanahan, B. Kiely, R. P. Ross, and C. Hill Antimicrobial activity of lacticin 3147 against clinical Clostridium difficile strains J. Med. Microbiol., July 1, 2007; 56(7): 940 - 946. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Aspevall, A. Lundberg, L. G. Burman, T. Akerlund, and B. Svenungsson Antimicrobial Susceptibility Pattern of Clostridium difficile and Its Relation to PCR Ribotypes in a Swedish University Hospital. Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1890 - 1892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 JournalScan Gut, January 1, 2004; 53(1): 153 - 153. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |
